会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • New derivatives of 6-{4-[4-(1h-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one
    • 6- {4- [4-(1H-吲哚-2-磺酰基) - 哌嗪-1-羰基 - 苯基]}嘧啶并[3'
    • US20070135441A1
    • 2007-06-14
    • US10584473
    • 2005-01-05
    • Emma BrattYantao ChenKenneth GranbergIngemar Nilsson
    • Emma BrattYantao ChenKenneth GranbergIngemar Nilsson
    • C07D403/14A61K31/501
    • C07D403/14
    • The invention relates to heterocyclic derivatives of formula (I), wherein R2 is amino, a group OR4 or a group —Y—R5 where R4 is hydrogen or C1-4alkyl, Y is C1-4alkylene, R5 is hydrogen, halo, hydroxy, C1-2alkoxy, C1-2alkoxyC1-2alkoxyC1-4, or a group NR7R8 where R7 and R8 are independently selected from hydrogen, C1-2alkyl, hydroxyC1-2alkyl or alkoxyC1-2alkyl, or R7 and R8 together with the nitrogen atom to which they are attached form a saturated 5-6-membered heterocyclic ring which optionally contains an additional heteroatom; n is one or two and each R1 is independently selected from halo, haloC1-2alkyl, hydroxy, oxo, amino C1-2alkylamino or di-C1-2dialkylamino; or a pharmaceutically acceptable salt thereof. These compounds possess antithrombotic and anticoagulant properties and are accordingly useful in methods of treatment of humans or animals. The invention also relates to processes for the preparation of the heterocyclic derivatives, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an antithrombotic or anticoagulant effect.
    • 本发明涉及式(I)的杂环衍生物,其中R 2是氨基,或OR 4或基团-YR 5,其中 R 4是氢或C 1-4烷基,Y是C 1-4亚烷基,R 5是 氢,卤素,羟基,C 1-12烷氧基,C 1-2烷氧基C 1-2烷氧基C 1-4, 或者其中R 7和R 8独立地选自氢,氢, C 1-12烷基,羟基C 1-12烷基或烷氧基C 1-12烷基,或R 7和/或 R 8与它们所连接的氮原子一起形成饱和的5-6元杂环,其任选地含有另外的杂原子; n是一个或两个,并且每个R 1独立地选自卤素,卤代C 1-2 - 烷基,羟基,氧代,氨基C 1-12 烷基氨基或二-C 1-2二烷基氨基; 或其药学上可接受的盐。 这些化合物具有抗血栓形成和抗凝血性质,因此可用于治疗人或动物的方法。 本发明还涉及制备杂环衍生物的方法,含有它们的药物组合物及其在制备用于产生抗血栓形成或抗凝血作用的药物中的用途。
    • 4. 发明授权
    • Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one
    • 6- {4- [4-(1H-吲哚-2-磺酰基) - 哌嗪-1-羰基 - 苯基]}嘧啶并三酮的衍生物
    • US07419979B2
    • 2008-09-02
    • US10584473
    • 2005-01-05
    • Emma BrattYantao ChenKenneth GranbergIngemar Nilsson
    • Emma BrattYantao ChenKenneth GranbergIngemar Nilsson
    • C07D403/12C07D403/14A61K31/501A61P7/02
    • C07D403/14
    • The invention relates to heterocyclic derivatives of formula (I), wherein R2 is amino, a group OR4 or a group —Y—R5 where R4 is hydrogen or C1-4alkyl, Y is C1-4alkylene, R5 is hydrogen, halo, hydroxy, C1-2alkoxy, C1-2alkoxyC1-2alkoxyC1-4, or a group NR7R8 where R7 and R8 are independently selected from hydrogen, C1-2alkyl, hydroxyC1-2alkyl or alkoxyC1-2alkyl, or R7 and R8 together with the nitrogen atom to which they are attached form a saturated 5-6-membered heterocyclic ring which optionally contains an additional heteroatom; n is one or two and each R1 is independently selected from halo, haloC1-2alkyl, hydroxy, oxo, amino, C1-2alkylamino or di-C1-2dialkylamino; or a pharmaceutically acceptable salt thereof. These compounds possess antithrombotic and anticoagulant properties and are accordingly useful in methods of treatment of humans or animals. The invention also relates to processes for the preparation of the heterocyclic derivatives, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an antithrombotic or anticoagulant effect.
    • 本发明涉及式(I)的杂环衍生物,其中R 2是氨基,或OR 4或基团-YR 5,其中 R 4是氢或C 1-4烷基,Y是C 1-4亚烷基,R 5是 氢,卤素,羟基,C 1-12烷氧基,C 1-2烷氧基C 1-2烷氧基C 1-4, 或者其中R 7和R 8独立地选自氢,氢, C 1-12烷基,羟基C 1-12烷基或烷氧基C 1-12烷基,或R 7和/或 R 8与它们所连接的氮原子一起形成饱和的5-6元杂环,其任选地含有另外的杂原子; n是一个或两个,并且每个R 1独立地选自卤素,卤代C 1-2 - 烷基,羟基,氧代,氨基,C 1-2 - 烷基氨基或二-C 1-2二烷基氨基; 或其药学上可接受的盐。 这些化合物具有抗血栓形成和抗凝血性质,因此可用于治疗人或动物的方法。 本发明还涉及制备杂环衍生物的方法,含有它们的药物组合物及其在制备用于产生抗血栓形成或抗凝血作用的药物中的用途。